When scientists develop new medicines, finding a molecule that binds tightly to its intended target often feels like a major breakthrough. But in antibody drug development, stronger binding does not always translate into a better medicine.
An antibody might recognize a disease-related protein extremely well yet struggle to remain stable during storage, form unwanted aggregates, or become too...